Characterization of MW06, a human monoclonal antibody with cross-neutralization activity against both SARS-CoV-2 and SARS-CoV

The global pandemic of COVID-19 caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in widespread social and economic disruption. Effective interventions are urgently needed for the prevention and treatment of COVID-19. Neutralizing monoclonal antibodies (mAbs) have d...

Descrición completa

Detalles Bibliográficos

Principais autores:	Wen Jiang, Junchao Wang, Shasha Jiao, Chenjian Gu, Wei Xu, Ben Chen, Rongjuan Wang, Huilin Chen, Youhua Xie, An Wang, Gang Li, Dadi Zeng, Jinchao Zhang, Min Zhang, Shuang Wang, Mingzhu Wang, Xun Gui
Formato:	Artigo
Idioma:	Inglês
Publicado:	Taylor & Francis Group 2021-01-01
Series:	mAbs
Assuntos:	SARS-cov-2 SARS-CoV ACE2 neutralization epitope antibody-dependent enhancement (ADE)
Acceso en liña:	https://www.tandfonline.com/doi/10.1080/19420862.2021.1953683
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!